Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 3, 2004, Pages 248-253

  Okamiya, Satoshi ^a   Ogino, Mieko ^a   Ogino, Yutaka ^a   Irie, Sachiko ^a   Kanazawa, Naomi ^a   Saito, Toyokazu ^a   Sakai, Fumihiko ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Double filtration plasmapheresis; Guillain Barr syndrome; Immunoadsorption; Plasma exchange; Plasmapheresis

Indexed keywords

TRYPTOPHAN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; DIALYSIS MEMBRANE; DISEASE SEVERITY; DOUBLE FILTRATION PLASMAPHERESIS; EVALUATION; FEMALE; FLUSHING; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; IMMUNOADSORPTION; MALE; OUTCOMES RESEARCH; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TECHNIQUE; TYRPTOPHAN IMMOBILIZED COLUMN BASED IMMUNOADSORPTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; HYPOTENSION; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; PLASMA EXCHANGE; PLASMAPHERESIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 3142618405     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00138.x     Document Type: Conference Paper

References (19)

1. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
2. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Efficiency of Plasma Exchange in Guillain-Barré Syndrome: Role of Replacement Fluids. Ann Neurol 1987;22:753-61.
3. Chen WH, Yeh JH, Chiu HC. Experience of Double Filtration Plasmapheresis in the Treatment of Guillain-Barré Syndrome. J Clin Apheresis 1999;14:126-9.
4. Diener HC, Haupt WF, Kloss TM et al. A Preliminary, Randomized, Multicenter Study Comparing Intravenous Immunoglobulin, Plasma Exchange, and Immune Adsorption in Guillain-Barré Syndrome. Eur Neurol 2001;46:107-9.
5. Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G. Sequential treatment of Guillain-Barré syndrome with extra-corporeal elimination and intravenous immunoglobulin. J Neurol Sci 1996;137:145-9.
6. Haupt WF, Birkmann C, van der Ven C, Pawlik G. Apheresis and Selective Adsorption Plus Immunoglobulin Treatment in Guillain-Barré Syndrome. Ther Apher 2000;4:198-200.
7. Shibuya N, Sato T, Osame M, Takegami T, Doi S, Kawanami S. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:578-81.
8. Yang KS, Kenpe K, Yamaji K, Tsuda H, Hashimoto H. Plasma Adsorption in Critical Care. Ther Apher 2002;6:184-8.
9. Asbury AK, Cornblath DR. Assessment of Current Diagnostic Criteria for Guillain-Barré Syndrome. Ann Neurol 1990;27:S21-4.
10. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled Trial of Prednisolone in Acute Polyneuropathy. Lancet 1978;2:750-3.
11. Greenwood RJ, Newsom-Davis J, Hughes RAC et al. Controlled Trial of Plasma Exchange in Acute Inflammatory Polyradiculoneuropathy. Lancet 1984;1:877-9.
12. van der Meché FGA, Schmitz PIM and the Dutch Guillain-Barré Study Group. A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain-Barré Syndrome. N Engl J Med 1992;326:1123-9.
13. Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndrome. Neurology 1996;46:100-3.
14. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
15. Tagawa Y, Yuki N, Hirata K. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption. J Neurol Sci 1998;157:90-5.
16. Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Ther Apher Dial 2003;7:85-90.
17. Goto H, Matsuo H, Nakane S et al. Plasmapheresis Affects T Helper Type-1/T Helper Type-2 Balance of Circulating Peripheral Lymphocytes. Ther Apher 2001;5:494-6.
18. H1 cytokines are augmented systematically early in Guillain-Barré syndrome. Neurology 2002;58:476-8.
19. Aarli JA. Role of Cytokines in Neurological Disorders. Curr Med Chem 2003;10:1931-7.